Endoscope Reprocessing Device Market Report 2026

The endoscope reprocessing device market size has grown strongly in recent years. It will grow from $2.48 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to growing number of endoscopic procedures worldwide, increasing focus on hospital infection control practices, rising adoption of reusable endoscopic instruments, expansion of healthcare infrastructure and diagnostic centers, advancements in automated cleaning and sterilization technologies.

The endoscope reprocessing device market size is expected to see strong growth in the next few years. It will grow to $3.45 billion by 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for automated reprocessing systems, rising investments in healthcare sterilization infrastructure, growing adoption of smart monitoring and tracking solutions, expansion of outpatient and ambulatory surgical facilities, increasing regulatory emphasis on endoscope reprocessing compliance. Major trends in the forecast period include increasing adoption of automated endoscope reprocessors in hospitals, rising demand for infection prevention and contamination control systems, growing preference for high-level disinfection technologies, expansion of centralized sterile services departments in healthcare facilities, increasing use of drying and storage cabinets for endoscope preservation.

The increasing prevalence of hospital acquired infections is expected to propel the growth of the endoscope reprocessing device market going forward. Hospital acquired infections (HAIs) refer to infections that patients develop during the course of receiving medical treatment within a healthcare facility, which were not present or incubating at the time of admission. The growing prevalence of HAIs is primarily contributing to rising clinical and operational challenges, driven by an increased volume of complex surgical procedures and diagnostic interventions that rely on reusable medical instruments across an aging global population. Endoscope reprocessing devices are supporting effective infection control by providing automated, standardized, and validated disinfection cycles that eliminate pathogenic microorganisms from flexible endoscopes, thereby preventing patient-to-patient transmission. For instance, in February 2025, according to the Health Security Agency, a UK-based national executive agency, hospital-onset healthcare-associated E. coli bacteremia cases increased to 676, representing a 1% rise compared to 669 cases in February 2024. Therefore, the increasing prevalence of hospital acquired infections is contributing to and propelling the growth of the endoscope reprocessing device market.

Leading companies operating in the endoscope reprocessing device market are focusing on product innovation such as advanced washer-disinfectors to enhance cleaning efficiency, improve sustainability, and streamline workflow automation in healthcare settings. Washer-disinfectors for endoscopes are automated systems designed to clean, disinfect, and dry flexible endoscopes, ensuring effective infection control and compliance with hygiene standards. For example, in June 2023, Olympus Corporation, a Japan-based medical technology company, launched the ETD Washer-Disinfector series, including ETD Basic and ETD Premium, as part of its infection prevention portfolio. These systems are designed to improve cleaning and disinfection efficiency, optimize water and energy consumption, and enhance workflow automation, targeting hospitals and endoscopy centers with high throughput requirements.

In November 2023, HOYA Corporation, a Japan-based provider of medical endoscopes, imaging systems, and reprocessing solutions, acquired the remaining 49% stake in WASSENBURG Medical B. V. for an undisclosed amount. Through this acquisition, HOYA aims to accelerate innovation in endoscope reprocessing solutions by combining Wassenburg's engineering expertise with its PENTAX Medical flexible endoscopy division, thereby strengthening its technological capabilities and market position. WASSENBURG Medical B. V. is a Netherlands-based provider of endoscope washer-disinfectors, drying cabinets, automated channel cleaning systems, consumables, and related services covering the full endoscope reprocessing cycle.

Major companies operating in the endoscope reprocessing device market are Münchener Medizin Mechanik GmbH, Ecolab Inc., Olympus Corporation, STERIS plc, Getinge AB, Shinva Medical Instrument Co. Ltd., Belimed AG, ARC Healthcare Solutions Inc., Olive Endoscopy Pvt. Ltd., Chemische Fabrik Dr. Weigert GmbH & Co. KG, Soluscope SAS, Matachana Group, SciCan Ltd., CISA Production S. r. l., LTE Scientific Ltd., Tuttnauer Ltd., Wassenburg Medical B. V., Sun Medical Systems Co. Ltd., ITPL Medical (India) Pvt. Ltd., Endo-Technik W. Griesat GmbH.

North America was the largest region in the endoscope reprocessing device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscope reprocessing device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the endoscope reprocessing device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endoscope reprocessing device market consists of sales of products including endoscope flushing systems, and high-level disinfection systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.